Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome

Takashi Kato, I. Tsuge, J. Inaba, K. Kato, T. Matsuyama, S. Kojima

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We report a case of an 11-year-old boy who underwent successful bone marrow transplantation for X-linked hyper-IgM syndrome (XHIM). The donor was an HLA-matched brother. The patient was conditioned with busulfan, cyclophosphamide and anti-thymocyte globulin. He received 4.7 x 108 marrow cells per kg from the donor. Prophylaxis against graft-versus-host disease consisted of cyclosporine and short-term methotrexate. The clinical course after the bone marrow transplantation was uneventful, and 12 months after transplantation the patient was doing well with no need for therapy. We examined expression of the CD40 ligand (CD40L) on the patient's activated T lymphocytes and in vitro production of immunoglobulins by his lymphocytes. Although expression of CD40L was totally absent before the bone marrow transplant, subnormal expression appeared after the transplantation. In vitro production of IgG and IgA also was improved by the transplant. Based on our experience bone marrow transplantation appears to be a reasonable therapeutic option for patients with XHIM if HLA-matched family donors are available.

Original languageEnglish
Pages (from-to)1081-1083
Number of pages3
JournalBone Marrow Transplantation
Volume23
Issue number10
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Type 1 Hyper-IgM Immunodeficiency Syndrome
Bone Marrow Transplantation
CD40 Ligand
Tissue Donors
Transplantation
Bone Marrow
Transplants
Busulfan
Antilymphocyte Serum
Graft vs Host Disease
Methotrexate
Cyclophosphamide
Immunoglobulin A
Cyclosporine
Immunoglobulins
Siblings
Immunoglobulin G
Lymphocytes
T-Lymphocytes
Therapeutics

Keywords

  • Bone marrow transplantation
  • CD40 ligand
  • X-linked hyper-IgM syndrome

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Kato, T., Tsuge, I., Inaba, J., Kato, K., Matsuyama, T., & Kojima, S. (1999). Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. Bone Marrow Transplantation, 23(10), 1081-1083.

Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. / Kato, Takashi; Tsuge, I.; Inaba, J.; Kato, K.; Matsuyama, T.; Kojima, S.

In: Bone Marrow Transplantation, Vol. 23, No. 10, 1999, p. 1081-1083.

Research output: Contribution to journalArticle

Kato, T, Tsuge, I, Inaba, J, Kato, K, Matsuyama, T & Kojima, S 1999, 'Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome', Bone Marrow Transplantation, vol. 23, no. 10, pp. 1081-1083.
Kato T, Tsuge I, Inaba J, Kato K, Matsuyama T, Kojima S. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. Bone Marrow Transplantation. 1999;23(10):1081-1083.
Kato, Takashi ; Tsuge, I. ; Inaba, J. ; Kato, K. ; Matsuyama, T. ; Kojima, S. / Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. In: Bone Marrow Transplantation. 1999 ; Vol. 23, No. 10. pp. 1081-1083.
@article{172ec97cf1f84c1399813cea7dfa0f06,
title = "Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome",
abstract = "We report a case of an 11-year-old boy who underwent successful bone marrow transplantation for X-linked hyper-IgM syndrome (XHIM). The donor was an HLA-matched brother. The patient was conditioned with busulfan, cyclophosphamide and anti-thymocyte globulin. He received 4.7 x 108 marrow cells per kg from the donor. Prophylaxis against graft-versus-host disease consisted of cyclosporine and short-term methotrexate. The clinical course after the bone marrow transplantation was uneventful, and 12 months after transplantation the patient was doing well with no need for therapy. We examined expression of the CD40 ligand (CD40L) on the patient's activated T lymphocytes and in vitro production of immunoglobulins by his lymphocytes. Although expression of CD40L was totally absent before the bone marrow transplant, subnormal expression appeared after the transplantation. In vitro production of IgG and IgA also was improved by the transplant. Based on our experience bone marrow transplantation appears to be a reasonable therapeutic option for patients with XHIM if HLA-matched family donors are available.",
keywords = "Bone marrow transplantation, CD40 ligand, X-linked hyper-IgM syndrome",
author = "Takashi Kato and I. Tsuge and J. Inaba and K. Kato and T. Matsuyama and S. Kojima",
year = "1999",
language = "English",
volume = "23",
pages = "1081--1083",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome

AU - Kato, Takashi

AU - Tsuge, I.

AU - Inaba, J.

AU - Kato, K.

AU - Matsuyama, T.

AU - Kojima, S.

PY - 1999

Y1 - 1999

N2 - We report a case of an 11-year-old boy who underwent successful bone marrow transplantation for X-linked hyper-IgM syndrome (XHIM). The donor was an HLA-matched brother. The patient was conditioned with busulfan, cyclophosphamide and anti-thymocyte globulin. He received 4.7 x 108 marrow cells per kg from the donor. Prophylaxis against graft-versus-host disease consisted of cyclosporine and short-term methotrexate. The clinical course after the bone marrow transplantation was uneventful, and 12 months after transplantation the patient was doing well with no need for therapy. We examined expression of the CD40 ligand (CD40L) on the patient's activated T lymphocytes and in vitro production of immunoglobulins by his lymphocytes. Although expression of CD40L was totally absent before the bone marrow transplant, subnormal expression appeared after the transplantation. In vitro production of IgG and IgA also was improved by the transplant. Based on our experience bone marrow transplantation appears to be a reasonable therapeutic option for patients with XHIM if HLA-matched family donors are available.

AB - We report a case of an 11-year-old boy who underwent successful bone marrow transplantation for X-linked hyper-IgM syndrome (XHIM). The donor was an HLA-matched brother. The patient was conditioned with busulfan, cyclophosphamide and anti-thymocyte globulin. He received 4.7 x 108 marrow cells per kg from the donor. Prophylaxis against graft-versus-host disease consisted of cyclosporine and short-term methotrexate. The clinical course after the bone marrow transplantation was uneventful, and 12 months after transplantation the patient was doing well with no need for therapy. We examined expression of the CD40 ligand (CD40L) on the patient's activated T lymphocytes and in vitro production of immunoglobulins by his lymphocytes. Although expression of CD40L was totally absent before the bone marrow transplant, subnormal expression appeared after the transplantation. In vitro production of IgG and IgA also was improved by the transplant. Based on our experience bone marrow transplantation appears to be a reasonable therapeutic option for patients with XHIM if HLA-matched family donors are available.

KW - Bone marrow transplantation

KW - CD40 ligand

KW - X-linked hyper-IgM syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033014727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033014727&partnerID=8YFLogxK

M3 - Article

C2 - 10373076

AN - SCOPUS:0033014727

VL - 23

SP - 1081

EP - 1083

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -